The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity ...

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

SPDR® S&P Biotech ETF is a well-diversified, low-cost ETF that can be an excellent tool to capitalize on the potential of the biotech stock sector. XBI's performance should be compared with the ...

VanEck Pharmaceutical ETF Price Performance PPH stock opened at $94.67 on Monday. The stock has a market capitalization of $728.01 million, a P/E ratio of 21.04 and a beta of 0.72. The business ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...